Gelsomino, F., Tiseo, M., Barbieri, F., Riccardi, F., Cavanna, L., Frassoldati, A., . . . Ardizzoni, A. (2020). Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL). Br J Cancer.
Chicago ZitierstilGelsomino, Francesco, et al. "Phase 2 Study of NAB-paclitaxel in SensiTivE and Refractory Relapsed Small Cell Lung Cancer (SCLC) (NABSTER TRIAL)." Br J Cancer 2020.
MLA ZitierstilGelsomino, Francesco, et al. "Phase 2 Study of NAB-paclitaxel in SensiTivE and Refractory Relapsed Small Cell Lung Cancer (SCLC) (NABSTER TRIAL)." Br J Cancer 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.